🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join us in Dundee for 3 days of fantastic respiratory science! The British Association for Lung Research (BALR) meeting 2024 features sessions on airways disease, neutrophils, microbiome, pulmonary fibrosis and much more! Loads of opportunities to present abstracts and awards to win! lena.events/2023/balr/

Congratulations Durrington Lab #WomenInScience

The most wonderful thing about conferences, alongside cutting edge & practice changing science, is the opportunity to catch up with friends & mentors Team Resp really is the absolute best 💙🫁💙🫁💙🫁💙 #RespIsBest #WomenInSTEM #BTSWinter2023 #WomenInMedicine #WomenInScience

Last day at #BTSWinter2023, packed with interesting, stimulating & hopeful talks on #COPD #PR #clinicaltrials and #immunomodulation to improve outcomes. But best bits of this trip were in catching with friends and colleagues of yester years. Look forward to seeing you all again!

🚨🚨HUGE COPD NEWS 🚨 🚨 NOTUS phase 3 study press release confirms the results of the BOREAS trial. Dupilumab works to reduce COPD exacerbations and improve lung function. Massive news for patients with COPD! Surya P Bhatt, MD, MSPH Mona Bafadhel Richard Russell sanofi.com/en/media-room/…

The first session of our Respiratory Conference in February will cover airways/COPD, chaired by David Anderson and Manish Patel. Speakers in this session include Mona Bafadhel, Hitasha Rupani and James D Chalmers. Find out more and book at: ow.ly/IjV950QfpBb Eric Livingston

John Hurst The Lancet Mona Bafadhel STARR2 However, I still see a role for FeNO in diagnosing inflammatory exacerbators in COPD and using OCS in COPD exacerbations thelancet.com/journals/lanre…

See you in #Glasgow at Glasgow Science Centre With @ProfChalmers and Mona Bafadhel to name but a few

Great to see that Gisli Jenkins Gisli Jenkins using "multi-morbidity" rather than co-morbidity One more of us, one less of them LOL Some more great names at Royal College of Physicians & Surgeons of Glasgow Respiratory Conference 2nd February Mona Bafadhel COPD Hitasha Rupani Severe Asthma James D Chalmers Bronchiestasis

In this study of 13208 patients with #COPD the QRISK3 score underestimated their 10 year risk of #cardiovascular events. On average, the observed risk was 52% higher than QRISK3 predicted (33.5% vs 22.1%), & more so in patients aged <65 years ThoraxBMJ thorax.bmj.com/content/early/…

WEBINAR: Updates on biologic treatments in COPD: Recent trials: 22nd March 2024 8:30am - 9:15am (GMT) thelimbic.com/uk/respiratory… Mona Bafadhel James D Chalmers

Julia Hippisley-Cox Mona Bafadhel Richard Russell Aziz Sheikh @PetBri RDM Oxford Uni of Nottingham Press Office King's Faculty of Life Sciences & Medicine Bristol Population Health Science Institute Asthma + Lung UK British Heart Foundation

Proud to have contributed to Q-risk4 heart disease calculator. #COPD is now in the risk calculator for the first time, helping better predict heart disease risk.

Published today the collaborative research, led by OxPrimaryCareSci, has developed a new tool that more accurately predicts risk of cardiovascular diseases. Mona Bafadhel Richard Russell

New research has identified COPD as an independent risk factor for developing cardiovascular disease. This work, as Mona Bafadhel so rightly puts it, underscores the need for monitoring lung function as an independent predictor of mortality and respiratory hospital admissions.

Women with COPD in particular are at a higher risk of cardiovascular diseases than previously thought. It's now critical that we focus on diagnosing COPD earlier to mitigate that risk + to allow researchers to develop better treatments. Congrats to King's College London OxPrimaryCareSci

If we're concerned about the imapct of sickness on productivity and the UK economy we could start with tackling the £188bn a year lung conditions cost the UK. #FundRespiratoryResearch bit.ly/461M7GT

The QR4 algorithm, a novel risk assessment tool for predicting🔟year cardiovascular disease💔Risk Incorporates7⃣novel risk factors for genders♂️♀️ ✅#BrainCancer 🧠 ✅#LungCancer 🫁 ✅Blood #Cancer 🩸 ✅#OralCancer 👄 ✅Down syndrome, ✅chronic obstructive ✅pulmonary

Day 2 of #BALR2024 kicks off early with Mona Bafadhel discussing exacerbations of COPD and asthma 🫁

Thanks for having me.